JPH0373523B2 - - Google Patents

Info

Publication number
JPH0373523B2
JPH0373523B2 JP8060683A JP8060683A JPH0373523B2 JP H0373523 B2 JPH0373523 B2 JP H0373523B2 JP 8060683 A JP8060683 A JP 8060683A JP 8060683 A JP8060683 A JP 8060683A JP H0373523 B2 JPH0373523 B2 JP H0373523B2
Authority
JP
Japan
Prior art keywords
drugs
strains
effects
combination
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8060683A
Other languages
English (en)
Japanese (ja)
Other versions
JPS606617A (ja
Inventor
Tsutomu Irikura
Keiji Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority to JP8060683A priority Critical patent/JPS606617A/ja
Publication of JPS606617A publication Critical patent/JPS606617A/ja
Publication of JPH0373523B2 publication Critical patent/JPH0373523B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP8060683A 1983-05-09 1983-05-09 抗菌性組成物 Granted JPS606617A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8060683A JPS606617A (ja) 1983-05-09 1983-05-09 抗菌性組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8060683A JPS606617A (ja) 1983-05-09 1983-05-09 抗菌性組成物

Publications (2)

Publication Number Publication Date
JPS606617A JPS606617A (ja) 1985-01-14
JPH0373523B2 true JPH0373523B2 (https=) 1991-11-22

Family

ID=13722986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8060683A Granted JPS606617A (ja) 1983-05-09 1983-05-09 抗菌性組成物

Country Status (1)

Country Link
JP (1) JPS606617A (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
JP2800939B2 (ja) * 1987-08-31 1998-09-21 大日本製薬株式会社 三環式化合物、そのエステルおよびその塩
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
ES2147721T3 (es) 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
KR100295742B1 (ko) * 1999-04-16 2001-07-03 이동규 동물용 복합항생제 조성물

Also Published As

Publication number Publication date
JPS606617A (ja) 1985-01-14

Similar Documents

Publication Publication Date Title
US4956179A (en) Antibacterial combination of penicillin and cephalosporin
Darrell et al. Trimethoprim: laboratory and clinical studies
JPH0373523B2 (https=)
JP6480870B2 (ja) 細菌感染を処置するための組成物および方法
JP2010527960A (ja) バイオフィルム形成の処置のためのトリアゾール化合物
Klastersky et al. Antipseudomonal drugs: comparative study of gentamicin, sisomicin and tobramycin in vitro and in human volunteers
Mitsuhashi Drug resistance in bacteria: history, genetics and biochemistry
Rudin et al. In vitro activity of ciprofloxacin against aerobic gram-negative bacteria
Korfhagen et al. Pseudomonas aeruginosa R factors determining gentamicin plus carbenicillin resistance from patients with urinary tract colonizations
Klinger et al. In-vitro activity of ciprofioxacin and other antibacterial agents against Pseudonwnas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients
US20060073156A1 (en) Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract
Bassey et al. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates
Limbert et al. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and β-lactamase stability
CH642850A5 (it) Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi.
US9265744B2 (en) Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria
WO1999059566A1 (en) Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection
Van Landuyt et al. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates
Fass Activity of mecillinam alone and in combination with other beta-lactam antibiotics
US4324783A (en) Antibacterial composition for medical use
Jones Cefotetan: a review of the microbiologic properties and antimicrobial spectrum
Kabins et al. R factor-mediated resistance to gentamicin in a clinical isolate of Escherichia coli
US4221781A (en) Synergistic penicillin-cephalosporin compositions and methods
US4898731A (en) Antibiotic combinations of penicillins
CN116077509B (zh) 鹿蹄草素与磺胺异恶唑组合物及其在抑制细菌中的应用
Adamsson et al. Influence of bacterial β-lactamase production on susceptibility in agar or broth to new cephalosporins